Anbio Biotechnology
NNNN
$6.57
$0.192.98%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.43% | -49.81% | -71.49% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.43% | -49.81% | -71.49% | -- | -- |
| Cost of Revenue | -11.92% | -52.56% | -69.48% | -- | -- |
| Gross Profit | 30.64% | -47.27% | -73.25% | -- | -- |
| SG&A Expenses | -57.66% | -50.28% | -41.65% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.62% | -51.04% | -64.41% | -- | -- |
| Operating Income | 184.63% | -47.65% | -80.77% | -- | -- |
| Income Before Tax | 184.88% | -42.91% | -77.49% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 184.88% | -42.91% | -77.49% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 184.88% | -42.91% | -77.49% | -- | -- |
| EBIT | 184.63% | -47.65% | -80.77% | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 750.94% | 900.00% | -- | -- | -- |
| Normalized Basic EPS | 754.55% | 903.03% | -- | -- | -- |
| EPS Diluted | 750.94% | 900.00% | -- | -- | -- |
| Normalized Diluted EPS | 754.55% | 903.03% | -- | -- | -- |
| Average Basic Shares Outstanding | 29.72% | 229.72% | -- | -- | -- |
| Average Diluted Shares Outstanding | 29.72% | 229.72% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |